BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ·Healthcare·Biotechnology
$54.79
-0.60%
Mkt Cap $10.65B
Analyst Ratings
Buy
17
Hold
5
Sell
0
Price Target (59 analysts)
$86.60
Range $60.00 – $105.00
Implied Upside
+58.1%
Consensus $86.60 vs current $54.79
NASDAQ·Healthcare·Biotechnology
$54.79
-0.60%
Mkt Cap $10.65B
Buy
17
Hold
5
Sell
0
Price Target (59 analysts)
$86.60
Range $60.00 – $105.00
+58.1%
Consensus $86.60 vs current $54.79